10:27 AM EST, 02/19/2025 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement.

The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday.

Shares of CNS Pharmaceuticals ( CNSP ) fell over 33% in recent trading.

Price: 0.10, Change: -0.05, Percent Change: -33.33